Prevalence of Electrolyte Imbalance in Chronic Kidney Disease:A Study at Tertiary Care Hospital in South Punjab,Pakistan

Chronic Kidney Diseases Clinical Trial

Official title:

Prevalence of Electrolyte Imbalance in Chronic Kidney Disease: A Study at Tertiary Care Hospitals in South Punjab, Pakistan

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03806088
• Other study ID #: IslamiaUS
• Status: Recruiting
• Start date: November 1, 2018
• Est. completion date: November 25, 2019

Study information

• Verified date: November 2019
• Source: Islamia University of Bahawalpur
• Contact: H M Attaullah, pharm.D
• Phone: 03044229043
• Email: attaullah[@]inbox.eu
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

an observational cross-sectional study is done to calculate the electrolyte imbalance at different stages of chronic kidney disease at tertiary care hospital.

Description:

an observational cross-sectional study is done to calculate the electrolyte imbalance at different stages of chronic kidney disease at tertiary care hospitals of south Punjab, Pakistan .The outcomes of chronic kidney disease and end stage of renal failure will be calculated according to standard protocol. Under the supervision of pathologists, pharmacologists, pharmacists, nephrologists, urologists and biostatistician. The standard protocol was authorized by ethical committee of each center. patient consent form was

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 385
• Est. completion date: November 25, 2019
• Est. primary completion date: November 25, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• CKD patients ranging

• age from 20-80

• dialysis and pre-dialysis patients

• who provide written consent form

Exclusion Criteria:

• congenital one kidney patients

• organ or kidney donors and transplantation

• pregnant women

• renal injury during trauma

Related Conditions & MeSH terms

• Chronic Kidney Diseases
• Kidney Diseases
• Renal Insufficiency, Chronic

Locations

Country	Name	City	State
Pakistan	Faculty of Pharmacy and Alternative Medicine Khawaja Freed Campus	Bahawalpur	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Islamia University of Bahawalpur

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Serum potassium in mEq/L	Serum potassium in mEq/L by taking blood sample under standard condition	2days
Primary	serum urea in mg/dl	serum urea in mg/dl by taking blood sample under standard condition	2days
Primary	Serum creatinine in mg/dl	Serum creatinine in mg/dl by taking blood sample under standard condition	2days
Primary	Serum calcium in mg/dl	Serum calcium in mg/dl by taking blood sample under standard condition	2days
Primary	Serum sodium in mEq/L	Serum sodium in mEq/L by taking blood sample under standard condition	2days
Secondary	Blood pressure in mm of Hg	Blood pressure in mm of Hg	2days
Secondary	Blood glucose concentration in mg/dl	Blood glucose concentration in mg/dl random	2days